Clinical Trial Update: Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 study at Duke University evaluating functional brain imaging as a measure of medication response in mild Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Duke University | Conditions: Alzheimer's Disease | Phase 4 | Status: TERMINATED